<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxics</journal-id><journal-id journal-id-type="iso-abbrev">Toxics</journal-id><journal-id journal-id-type="publisher-id">toxics</journal-id><journal-title-group><journal-title>Toxics</journal-title></journal-title-group><issn pub-type="epub">2305-6304</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39997953</article-id><article-id pub-id-type="pmc">PMC11860940</article-id>
<article-id pub-id-type="doi">10.3390/toxics13020138</article-id><article-id pub-id-type="publisher-id">toxics-13-00138</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Network Pharmacology to Unveil the Mechanism of Berberine in the Treatment of <italic toggle="yes">Streptococcus suis</italic> Meningitis in Humans and Pigs</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Pu</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref><xref rid="fn1-toxics-13-00138" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Yunda</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref><xref rid="fn1-toxics-13-00138" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Dan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Qirong</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yu</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Xiong</surname><given-names>Jianglin</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Chun</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Shulin</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Zhongyuan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6476-0509</contrib-id><name><surname>Wang</surname><given-names>Xu</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af3-toxics-13-00138" ref-type="aff">3</xref><xref rid="c1-toxics-13-00138" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Yinsheng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-toxics-13-00138" ref-type="aff">1</xref><xref rid="af2-toxics-13-00138" ref-type="aff">2</xref><xref rid="c1-toxics-13-00138" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Wang</surname><given-names>Chiachi</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-toxics-13-00138"><label>1</label>Hubei Key Laboratory of Animal Nutrition and Feed Science, School of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan 430023, China; <email>guopu@whpu.edu.cn</email> (P.G.); <email>xue18337292680@163.com</email> (Y.X.); <email>15823132897@163.com</email> (D.Z.); <email>qirongluvet@whpu.edu.cn</email> (Q.L.); <email>lyywfy@whpu.edu.cn</email> (Y.L.); <email>xiongjianglin@126.com</email> (J.X.); <email>yechun@whpu.edu.cn</email> (C.Y.); <email>shulinfu@whpu.edu.cn</email> (S.F.); <email>zhongywu@whpu.edu.cn</email> (Z.W.)</aff><aff id="af2-toxics-13-00138"><label>2</label>Wuhan Engineering and Technology Research Center of Animal Disease-Resistant Nutrition, School of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan 430023, China</aff><aff id="af3-toxics-13-00138"><label>3</label>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China</aff><author-notes><corresp id="c1-toxics-13-00138"><label>*</label>Correspondence: <email>wangxu@mail.hzau.edu.cn</email> (X.W.); <email>qiuyinsheng6405@whpu.edu.cn</email> (Y.Q.); Tel./Fax: +86-27-87282019 (X.W.); +86-27-83956175 (Y.Q.)</corresp><fn id="fn1-toxics-13-00138"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>15</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>138</elocation-id><history><date date-type="received"><day>09</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>10</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>13</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic toggle="yes">Streptococcus suis</italic> (<italic toggle="yes">S. suis</italic>) is a major swine pathogen throughout the world as well as an emerging zoonotic agent. Among the symptoms caused by <italic toggle="yes">S. suis</italic>, including septicemia, pneumonia, endo-carditis, arthritis, and meningitis, the latter is the most overlooked. In the present study, we explored the mechanism of action of berberine against <italic toggle="yes">S. suis</italic> meningitis by obtaining berberine-related action targets, porcine <italic toggle="yes">S. suis</italic> meningitis targets, and human <italic toggle="yes">S. suis</italic> meningitis targets from open databases. We constructed a protein&#x02013;protein interaction (PPI) network by using the STRING database and employed Cytoscape 3.8.0 to screen for core targets. We performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses through DAVID. We identified 31 potential targets of berberine, of which Toll-like receptor 4 (TLR4), fibronectin 1 (FN1), superoxide dismutase (SOD1), and catalase (CAT) were the four most critical targets. GO analysis revealed the enrichment of terms related to the response to oxidative stress and the inflammatory response. KEGG analysis revealed the enrichment of the interleukin 17 (IL-17), phosphoinositide 3-kinase (PI3K)-Akt, TLR, tumor necrosis factor (TNF), and mitogen-activated protein kinase (MAPK) signaling pathways. In addition, the admetSAR results showed that berberine can cross the blood&#x02013;brain barrier. The molecular docking results indicated key binding activity between TLR4&#x02013;berberine and FN1&#x02013;berberine. In summary, berberine protects against <italic toggle="yes">Streptococcus suis</italic> meningitis by regulating inflammatory response and oxidative stress in humans and pigs. Our study updates the current knowledge of the targets of <italic toggle="yes">S. suis</italic> meningitis to exploit new drugs in humans and pigs, to develop environmentally friendly and antibiotic-free animal-derived food products, and to improve the farming industry and economic development.</p></abstract><kwd-group><kwd>berberine</kwd><kwd><italic toggle="yes">S. suis</italic></kwd><kwd>meningitis</kwd><kwd>anti-inflammatory</kwd><kwd>anti-oxidative stress</kwd><kwd>network pharmacology</kwd></kwd-group><funding-group><award-group><funding-source>Key Research and Development Plan of Hubei Province, China</funding-source><award-id>2023BBB069</award-id></award-group><funding-statement>This work was supported by Key Research and Development Plan of Hubei Province, China (2023BBB069).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-toxics-13-00138"><title>1. Introduction</title><p><italic toggle="yes">Streptococcus suis</italic> (<italic toggle="yes">S. suis</italic>), a Gram-positive bacterium, is a major swine pathogen and causes considerable economic losses in the swine industry [<xref rid="B1-toxics-13-00138" ref-type="bibr">1</xref>]. As an important zoonotic pathogen, <italic toggle="yes">S. suis</italic> can cause septicemia, pneumonia, endocarditis, arthritis, and meningitis, with irreversible sequelae in pigs and humans [<xref rid="B2-toxics-13-00138" ref-type="bibr">2</xref>,<xref rid="B3-toxics-13-00138" ref-type="bibr">3</xref>]. Meningitis, a symptom that is often overlooked, has begun to receive attention in recent years due to the increasing number of reported cases. In one study, <italic toggle="yes">S. suis</italic> was isolated from 95% of the sampled pigs in both the case (previously diagnosed <italic toggle="yes">S. suis</italic> infections) and control (clinically healthy Swedish pigs) herds. Moreover, 8 of the 10 case herds showed clinical signs indicative of meningitis [<xref rid="B4-toxics-13-00138" ref-type="bibr">4</xref>]. <italic toggle="yes">S. suis</italic> infection not only sharply reduces the economic benefits of pig farming but also has severe effects on humans. It can be transmitted to humans by eating undercooked pork or by slaughtering sick pigs.</p><p>The number of <italic toggle="yes">S. suis</italic> infections in humans has increased substantially. From July to August 2005, there has been a large-scale public health crisis in Sichuan due to <italic toggle="yes">S. suis</italic> infection. A total of 215 cases of <italic toggle="yes">S. suis</italic> infection were reported, resulting in 38 deaths, and 48% of the infected patients had meningitis [<xref rid="B5-toxics-13-00138" ref-type="bibr">5</xref>]. Recently, Hospital Universitario de Canarias presented a case report of meningitis with associated secondary bacteremia due to <italic toggle="yes">S. suis</italic> infection in a 56-year-old man [<xref rid="B6-toxics-13-00138" ref-type="bibr">6</xref>]. In a case-based surveillance for bacterial meningitis in Burkina Faso, from 2015 to 2018, there were 38 cases of meningitis among 590 people who were polymerase chain reaction (PCR) positive for three nonpneumococcal streptococcal pathogens; 21 of these cases involved <italic toggle="yes">S. suis</italic> infection. The 21 <italic toggle="yes">S. suis</italic>-positive patients were of different ages, the majority were male (16, 76.2%), and 2 (9.5%) patients died [<xref rid="B7-toxics-13-00138" ref-type="bibr">7</xref>]. In an Indonesian study, of 71 acute bacterial meningitis cases, <italic toggle="yes">S. suis</italic> was confirmed in the cerebrospinal fluid culture of 44 patients with an average age of 48.1 years; 89% of the patients were male [<xref rid="B8-toxics-13-00138" ref-type="bibr">8</xref>]. Two studies in Thailand showed that <italic toggle="yes">S. suis</italic> infections in humans are responsible for an estimated loss in productivity-adjusted life years to the gross domestic product of USD 11.3 million, which equals USD 36,033 lost per person and USD 140 out-of-pocket expenses for each patient [<xref rid="B9-toxics-13-00138" ref-type="bibr">9</xref>,<xref rid="B10-toxics-13-00138" ref-type="bibr">10</xref>].</p><p>At present, the target(s) of <italic toggle="yes">S. suis</italic> meningitis in pigs and humans and its pathogenic mechanism remain unknown, meaning that there are great obstacles to the treatment of the disease and the creation of novel anti-streptococcal meningitis drugs. The search for highly effective preventive and therapeutic drugs with few side effects will help to strengthen the prevention of this disease, reduce the risk of infection and transmission among practitioners and the morbidity and mortality of porcine and human meningitis, improve the efficiency of farming, and contribute to modernizing the swine industry and disease prevention and control.</p><p>Berberine is a plant alkaloid found in the roots and bark of a variety of plants, including Coptis chinensis (goldenthread), Berberis aquifolium (Oregon grape), Berberis vulgaris (barberry), Hydrastis canadensis (goldenseal), and Berberis aristata (tree turmeric). Berberine exhibits a wide range of pharmacological effects, including anti-inflammatory, antioxidant, immunomodulatory, anti-tumor, and antibacterial activities [<xref rid="B11-toxics-13-00138" ref-type="bibr">11</xref>,<xref rid="B12-toxics-13-00138" ref-type="bibr">12</xref>,<xref rid="B13-toxics-13-00138" ref-type="bibr">13</xref>,<xref rid="B14-toxics-13-00138" ref-type="bibr">14</xref>]. Berberine has a good bacteriostatic effect on <italic toggle="yes">S. suis</italic>, with a minimum inhibitory concentration (MIC) of 0.19 mM [<xref rid="B15-toxics-13-00138" ref-type="bibr">15</xref>]. Berberine could reduce cerebral hemorrhage-induced neurological deficits and inflammatory cytokine production, inhibit inflammatory responses, and protect the integrity of the blood&#x02013;brain barrier in a mouse cerebral hemorrhage brain injury model established by injecting autologous whole blood [<xref rid="B16-toxics-13-00138" ref-type="bibr">16</xref>]. Moreover, berberine could effectively reduce doxorubicin-induced neuroinflammation and oxidative stress, suggesting that this compound exerts a favorable neuroprotective effect through its antioxidant and anti-inflammatory activities at the level of nerve inflammasome [<xref rid="B17-toxics-13-00138" ref-type="bibr">17</xref>]. Furthermore, in a rat model of chronic cerebral hypoperfusion, berberine hydrochloride restored chronic cerebral hypoperfusion-induced neuronal damage and counteracted cognitive impairment [<xref rid="B18-toxics-13-00138" ref-type="bibr">18</xref>], indicating that berberine may be useful to treat neuroinflammation and neurodegenerative disorders.</p><p>The active ingredients in traditional Chinese medicine can act through various targets and have complex routes of action. Given that the mechanism of action of berberine against <italic toggle="yes">S. suis</italic> meningitis remains unclear, we constructed a component&#x02013;disease pathway&#x02013;target network to analyze the relevant targets based on network pharmacology and to establish the research foundation for elucidating the mechanism by which berberine ameliorated <italic toggle="yes">S. suis</italic> meningitis in pigs and humans. In addition, we suggest a new approach to manage and avoid streptococcal meningitis by actively pushing for novel veterinary feeds derived from the same food and medicine source and minimizing the use of antibiotics.</p></sec><sec id="sec2-toxics-13-00138"><title>2. Materials and Methods</title><p>The study strategy is illustrated in <xref rid="toxics-13-00138-f001" ref-type="fig">Figure 1</xref>.</p><sec id="sec2dot1-toxics-13-00138"><title>2.1. Screening of Berberine Targets</title><p>Berberine targets were obtained from SwissTargetPrediction (<uri xlink:href="http://www.swisstargetprediction.ch">http://www.swisstargetprediction.ch</uri>) [<xref rid="B19-toxics-13-00138" ref-type="bibr">19</xref>] and the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (<uri xlink:href="https://www.tcmsp-e.com">https://www.tcmsp-e.com</uri>) [<xref rid="B20-toxics-13-00138" ref-type="bibr">20</xref>]. The targets were supplemented by referring to the literature collected at the National Center for Biotechnology Information (NCBI; <uri xlink:href="https://www.ncbi.nlm.nih.gov">https://www.ncbi.nlm.nih.gov</uri>). All targets were combined and then deduplicated. Meanwhile, the structure of berberine was imported to admetSAR (<uri xlink:href="http://lmmd.ecust.edu.cn/admetsar2">http://lmmd.ecust.edu.cn/admetsar2</uri>) [<xref rid="B21-toxics-13-00138" ref-type="bibr">21</xref>] to predict its pharmacokinetics and toxicity.</p></sec><sec id="sec2dot2-toxics-13-00138"><title>2.2. Screening of S. suis Meningitis Targets</title><p>The PubMed database was searched to identify <italic toggle="yes">S. suis</italic> meningitis targets by using the keywords &#x0201c;porcine <italic toggle="yes">S. suis</italic> meningitis&#x0201d;. Human <italic toggle="yes">S. suis</italic> meningitis targets were collected from GeneCards (<uri xlink:href="https://www.genecards.org">https://www.genecards.org</uri>) [<xref rid="B22-toxics-13-00138" ref-type="bibr">22</xref>], NCBI (<uri xlink:href="https://www.ncbi.nlm.nih.gov">https://www.ncbi.nlm.nih.gov</uri>), PharmGKB (<uri xlink:href="https://www.pharmgkb.org">https://www.pharmgkb.org</uri>) [<xref rid="B23-toxics-13-00138" ref-type="bibr">23</xref>], and the Therapeutic Target Database (TTD; <uri xlink:href="https://db.idrblab.net/ttd">https://db.idrblab.net/ttd</uri>) [<xref rid="B24-toxics-13-00138" ref-type="bibr">24</xref>] by using the same keywords. Duplicates were removed to obtain a list of the two lists of potential disease targets.</p></sec><sec id="sec2dot3-toxics-13-00138"><title>2.3. Prediction of Potential Targets of Berberine in Treating S. suis Meningitis</title><p>The list of identified berberine, porcine <italic toggle="yes">S. suis</italic> meningitis, and human <italic toggle="yes">S. suis</italic> meningitis targets were imported to the Venny 2.1 software, which generated a Venn diagram to identify the targets of berberine that could ameliorate <italic toggle="yes">S. suis</italic> meningitis.</p></sec><sec id="sec2dot4-toxics-13-00138"><title>2.4. Construction of a Protein&#x02013;Protein Interaction (PPI) Network</title><p>The STRING database (<uri xlink:href="https://string-db.org">https://string-db.org</uri>) was used to construct a PPI network of the potential target sets, with the biological species set to <italic toggle="yes">Sus scrofa</italic> and the minimum interaction score set to medium confidence (0.400). The file was saved in the tsv format and imported into the Cytoscape 3.8.0 software [<xref rid="B25-toxics-13-00138" ref-type="bibr">25</xref>] for topological analysis. The genes were sorted according to the degree values. Genes with scores greater than the average were selected as the core targets.</p></sec><sec id="sec2dot5-toxics-13-00138"><title>2.5. Molecular Docking</title><p>Molecular docking was performed for the top four critical berberine protein targets to alleviate <italic toggle="yes">S. suis</italic> meningitis in pigs and human. The structure of the active pharmaceutical ingredient was downloaded from the PubChem database and imported into the ChemBio3D 14.0 software for processing; the energy was minimized and saved as a ligand. In the Uniprot database (<uri xlink:href="https://www.uniprot.org">https://www.uniprot.org</uri>), the three-dimensional (3D) structure of the <italic toggle="yes">Sus scrofa</italic> (<italic toggle="yes">S. scrofa</italic>) target protein predicted by AlphaFold and the 3D structure of the <italic toggle="yes">Homo sapiens</italic> target protein download from the Protein Data Bank (<uri xlink:href="https://www.rcsb.org">https://www.rcsb.org</uri>) was exported. The SYBYL-X 2.0 software [<xref rid="B26-toxics-13-00138" ref-type="bibr">26</xref>] was used to simulate the ligand&#x02013;receptor docking, the PyMOL 3.1.3.1 software [<xref rid="B27-toxics-13-00138" ref-type="bibr">27</xref>] was used to visualize the model ligand&#x02013;receptor 3D diagrams, and LigPlot+ v.2.2 software was used to obtain 2D images.</p></sec><sec id="sec2dot6-toxics-13-00138"><title>2.6. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) Enrichment Analyses</title><p>GO and KEGG enrichment analysis was performed for the potential targets via DAVID (<uri xlink:href="https://david.ncifcrf.gov">https://david.ncifcrf.gov</uri>). The relevant genes were uploaded, the species was set to <italic toggle="yes">S. scrofa</italic>, and the <italic toggle="yes">p</italic>-value was set to &#x0003c;0.05. The enrichment results were processed using bioinformatics (<uri xlink:href="http://www.bioinformatics.com.cn">http://www.bioinformatics.com.cn</uri>) to obtain histograms and bubble charts.</p></sec></sec><sec sec-type="results" id="sec3-toxics-13-00138"><title>3. Results</title><sec id="sec3dot1-toxics-13-00138"><title>3.1. Screening of the Potential Berberine Targets in Treating S. suis Meningitis</title><p>The berberine, porcine <italic toggle="yes">S. suis</italic> meningitis, and human <italic toggle="yes">S. suis</italic> meningitis targets are summarized in <xref rid="toxics-13-00138-f002" ref-type="fig">Figure 2</xref>. We identified 350 berberine targets (<xref rid="toxics-13-00138-f002" ref-type="fig">Figure 2</xref>A), 490 porcine <italic toggle="yes">S. suis</italic> meningitis targets (<xref rid="toxics-13-00138-f002" ref-type="fig">Figure 2</xref>B), and 583 human <italic toggle="yes">S. suis</italic> meningitis targets (<xref rid="toxics-13-00138-f002" ref-type="fig">Figure 2</xref>C). Moreover, the admetSAR results demonstrated that berberine can cross the blood&#x02013;brain barrier, can be absorbed by the intestine, and do not exert teratogenicity or nephrotoxicity (<xref rid="toxics-13-00138-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3dot2-toxics-13-00138"><title>3.2. Screening of Common Targets of Berberine and S. suis Meningitis</title><p>The potential target sets are summarized in a Venn diagram (<xref rid="toxics-13-00138-f002" ref-type="fig">Figure 2</xref>D). There are four common porcine <italic toggle="yes">S. suis</italic> meningitis and human <italic toggle="yes">S. suis</italic> meningitis targets, namely, Toll-like receptor 4 (TLR4), fibronectin (FN1), superoxide dismutase1 (SOD1), and catalase (CAT).</p></sec><sec id="sec3dot3-toxics-13-00138"><title>3.3. Analysis of the PPI Network and Screening of Core Targets</title><p>We submitted the target proteins to STRING version 11.0 (<uri xlink:href="http://string-db.org">http://string-db.org</uri>) to construct a PPI network, which includes 11 core targets, including TLR4, FN1, SOD1, CAT, tumor necrosis factor (TNF), transforming growth factor beta (TGF-&#x003b2;), tumor protein P53 (TP53), caspase-3 (CASP3), mitogen-associated protein kinase 14 (MAPK14), intercellular adhesion mole9ocule 1 (ICAM-1), and heme oxygenase 1 (HMOX1) (<xref rid="toxics-13-00138-f003" ref-type="fig">Figure 3</xref>). Among them, TLR4, FN1, SOD1, and CAT are the most critical targets; they could represent the targets by which berberine alleviates <italic toggle="yes">S. suis</italic> meningitis.</p></sec><sec id="sec3dot4-toxics-13-00138"><title>3.4. Molecular Docking Rresults</title><p>Berberine and the most critical targets TLR4, FN1, SOD1, and CAT were evaluated by molecular docking. The results showed that berberine has a good docking activity to bind the docking pocket of each target protein, and the main forces involved were hydrophobic forces and hydrogen bonds (<xref rid="toxics-13-00138-f004" ref-type="fig">Figure 4</xref>). These interactions might play key roles in the mechanism by which berberine alleviates <italic toggle="yes">S. suis</italic> meningitis. Berberine binds to TLR4 by forming hydrogen bonds with Ser360 (docking score = 4.17) (<xref rid="toxics-13-00138-f004" ref-type="fig">Figure 4</xref>A,a) and Lys130 (docking score = 4.19) (<xref rid="toxics-13-00138-f004" ref-type="fig">Figure 4</xref>B,b) of humans and pigs, respectively. Similarly, berberine is predicted to dock via hydrogen bonds Arg2043 (docking score = 3.78) (<xref rid="toxics-13-00138-f004" ref-type="fig">Figure 4</xref>C,c) and Arg504, Arg2148, and Ser2303 (docking score = 4.35) (<xref rid="toxics-13-00138-f004" ref-type="fig">Figure 4</xref>D,d) in the binding pocket of FN1 of humans and pigs, respectively. However, SOD1 and cat had low docking scores. Thus, berberine may affect its function by competitively inhibiting the binding of the docking pocket to the TLR4 and FN1 target receptors. These interactions might play roles in alleviating <italic toggle="yes">S. suis</italic> meningitis in pigs and humans.</p></sec><sec id="sec3dot5-toxics-13-00138"><title>3.5. GO and KEGG Enrichment Analysis and the Component&#x02013;Disease Pathway&#x02013;Target Network</title><p>We performed GO and KEGG enrichment analyses of the potential targets by using DAVID to clarify the role of core targets in biology and signal transduction pathways. As shown in <xref rid="toxics-13-00138-f005" ref-type="fig">Figure 5</xref>A, GO analysis revealed the enrichment of biological processes such as the positive regulation of the extracellular-signal-regulated kinase 1 (ERK1) and ERK2 cascade, the inflammatory response, and the response to oxidative stress. The KEGG enrichment analysis showed the enrichment of the interleukin 17 (IL-17), phosphoinositide 3-kinase (PI3K)-Akt, TLR, TNF, and MAPK signaling pathways (<xref rid="toxics-13-00138-f005" ref-type="fig">Figure 5</xref>B). Overall, the enrichment of proteins that are closely related to oxidative stress, the inflammatory response, and their related signaling pathways were showed by GO and KEGG analyses. Hence, berberine may alleviate <italic toggle="yes">S. suis</italic> meningitis in pigs and humans by regulating oxidative stress and inflammatory signaling pathways.</p></sec></sec><sec sec-type="discussion" id="sec4-toxics-13-00138"><title>4. Discussion</title><p>Pigs of any age can be infected with streptococcal meningitis, a common disease in the livestock and pig-farming industries. Among them, nursing piglets and weaned piglets are high-risk groups. With the widespread outbreak of streptococcal disease in pigs, there have been increasing reports of human infections and cases of fatalities, posing a serious threat to human health and causing significant economic losses [<xref rid="B10-toxics-13-00138" ref-type="bibr">10</xref>,<xref rid="B28-toxics-13-00138" ref-type="bibr">28</xref>]. Therefore, it is crucial to strengthen research on <italic toggle="yes">S. suis</italic> meningitis in pigs and humans, to reduce the harm caused by the disease, and to develop effective preventive and therapeutic drugs.</p><p>We used network pharmacology methods to predict the functional targets of berberine in the treatment of <italic toggle="yes">S. suis</italic> meningitis in pigs. We screened a total of 31 potential targets, and the PPI network analysis showed that the core targets of berberine include TLR4, FN1, SOD1, CAT, TNF, TGF-&#x003b2;, TP53, CASP3, MAPK14, ICAM-1, and HMOX1, indicating that berberine may exert therapeutic effects on <italic toggle="yes">S. suis</italic> meningitis through multiple targets and pathways. GO and KEGG enrichment analyses revealed that berberine is mainly associated with processes such as the lipopolysaccharide-mediated signaling pathway, oxidative stress, protein binding, kinase activity, extracellular fluid, the cytoplasm, protein binding, and metal ion binding. At the same time, berberine may exert therapeutic effects on <italic toggle="yes">S. suis</italic> meningitis by mediating neurodegenerative signaling pathways and inflammation via the IL-17, PI3K-Akt, TNF, TLR, and MAPK signaling pathways.</p><p>TLR4 is a crucial regulatory factor in inflammation. As a pattern recognition receptor, TLR4 is expressed in a range of cells, including microglia, astrocytes, and neurons and plays an important role in regulating the inflammatory response to stress [<xref rid="B29-toxics-13-00138" ref-type="bibr">29</xref>,<xref rid="B30-toxics-13-00138" ref-type="bibr">30</xref>,<xref rid="B31-toxics-13-00138" ref-type="bibr">31</xref>]. Activating TLR4 signaling will lead to the nuclear factor kappa-light-chain-enhancer of activated B cell (NF-&#x003ba;B) expression and the production of the pro-inflammatory cytokines TNF, IL-1&#x003b2;, and IL-6 and the activation of MAPK pathways, leading to pro-inflammatory effects and neuroinflammation in the abovementioned cells [<xref rid="B32-toxics-13-00138" ref-type="bibr">32</xref>,<xref rid="B33-toxics-13-00138" ref-type="bibr">33</xref>]. In addition, TNF directly drives inflammatory responses by inducing the expression of inflammatory genes and indirectly promotes inflammation and immune responses as well as disease development by inducing cell death and activating the MAPK and NF-&#x003ba;B signaling pathways to promote the expression of inflammatory genes [<xref rid="B34-toxics-13-00138" ref-type="bibr">34</xref>].</p><p>In addition, damage to the tight connections of the blood&#x02013;brain barrier is also an important target of <italic toggle="yes">S. suis</italic> meningitis. FN1 exists as a dimer or multimer in plasma, on cell surfaces, and in the extracellular matrix and is involved in processes such as cell migration and adhesion [<xref rid="B35-toxics-13-00138" ref-type="bibr">35</xref>,<xref rid="B36-toxics-13-00138" ref-type="bibr">36</xref>,<xref rid="B37-toxics-13-00138" ref-type="bibr">37</xref>]. It is associated with a poor prognosis in diseases such as glioma, gastric cancer, and thyroid cancer [<xref rid="B38-toxics-13-00138" ref-type="bibr">38</xref>,<xref rid="B39-toxics-13-00138" ref-type="bibr">39</xref>] and is highly expressed in patients with neuroinflammation and glioblastoma [<xref rid="B40-toxics-13-00138" ref-type="bibr">40</xref>,<xref rid="B41-toxics-13-00138" ref-type="bibr">41</xref>]. FN1 overexpression can affect the immune microenvironment and cause immune cell infiltration. The loss of FN1 can inhibit the proliferation and migration of glioblastoma cells [<xref rid="B42-toxics-13-00138" ref-type="bibr">42</xref>]. These studies indicate that the overexpression of FN1 promotes the development of bacterial infection-induced central nervous system inflammation, suggesting that FN1 may be an important target in bacterial meningitis.</p><p>SOD1 is an enzyme with antioxidant activity that maintains the balance between oxidation and antioxidation in the body, protects the normal function of brain cells, and plays a crucial role in clearing excess free radicals [<xref rid="B43-toxics-13-00138" ref-type="bibr">43</xref>]. In a mouse model with a 50% reduction in SOD1 protein expression (Sod1+/&#x02212;), the lower protein levels cause motor dysfunction and increase neurodegeneration and the sensitivity to other cellular stresses such as cerebral ischemia, leading to increased blood&#x02013;brain barrier permeability [<xref rid="B44-toxics-13-00138" ref-type="bibr">44</xref>]. Hence, the sensitivity of neurons to oxidative damage seems to be dependent on the lack of SOD1. HMOX1, a classical antioxidant protein, exerts anti-inflammatory and antioxidant effects when activated [<xref rid="B45-toxics-13-00138" ref-type="bibr">45</xref>,<xref rid="B46-toxics-13-00138" ref-type="bibr">46</xref>]. Patients with HMOX1 deficiency and mice with Hmox1 gene deletion show increased inflammation and increased susceptibility to oxidative stress [<xref rid="B47-toxics-13-00138" ref-type="bibr">47</xref>], indicating that HMOX1 is an important regulator of antioxidant and anti-inflammatory responses.</p><p>We speculate that after <italic toggle="yes">S. suis</italic> invades the host, it increases the levels of TLR4, TNF, and FN1, leading to the release of a large amount of superoxide anions and nitric oxide (NO), thus resulting in oxidative stress. These changes would trigger a series of reactions leading to blood&#x02013;brain barrier disruption, inflammatory damage, and nerve injury. As a result, cells are severely damaged, leading to meningitis. The body may resist <italic toggle="yes">S. suis</italic> meningitis by regulating anti-inflammatory and antioxidant genes such as HMOX1 and SOD1 and inhibiting the expression of inflammatory factors such as TNF.</p><p>Continuous in-depth research on traditional Chinese herbs and the active ingredients of Chinese medicine has provided new insights into the treatment of diseases. Berberine, a component of several traditional Chinese herbs, has good anti-inflammatory activity and can reduce the expression of various inflammatory cytokines such as TNF-&#x003b1;, thereby exerting anti-inflammatory effects [<xref rid="B48-toxics-13-00138" ref-type="bibr">48</xref>]. Berberine can inhibit TGF-&#x003b2;1, upregulate E-cadherin expression, increase cell adhesion, and decrease cell migration [<xref rid="B16-toxics-13-00138" ref-type="bibr">16</xref>]. It can also inhibit the phosphorylation of c-Jun N-terminal kinase (JNK) and NF-&#x003ba;B to suppress the activation of the TAK1/JNK and TAK1/NF-&#x003ba;B signaling pathways, thereby reducing the expression of ICAM-1, inhibiting the expression of TGF-&#x003b2; and some inflammatory factors, such as IL-1&#x003b2;, IL-6, and TNF-&#x003b1;, and alleviating inflammation [<xref rid="B49-toxics-13-00138" ref-type="bibr">49</xref>].</p><p>Berberine can also increase the activity of SOD and CAT in mice and decrease the level of kidney injury molecule-1 (KIM-1), NO, malondialdehyde (MDA), TNF-&#x003b1;, and IL-1&#x003b2; to reduce oxidative stress and inflammatory effects [<xref rid="B50-toxics-13-00138" ref-type="bibr">50</xref>,<xref rid="B51-toxics-13-00138" ref-type="bibr">51</xref>]. Similarly, berberine can participate in the TLR4 signaling pathway to alleviate inflammatory reactions, significantly reduce reactive oxygen species levels, enhance the antioxidant defense, induce the expression of Nrf2 and HOMX1 through the PI3K/Akt pathway, and alleviate oxidative stress [<xref rid="B52-toxics-13-00138" ref-type="bibr">52</xref>]. Based on these functions, we speculate that berberine regulates the levels of TGF-&#x003b2;, TNF-&#x003b1;, ICAM-1, TLR4, and FN1; induces the expression of anti-inflammatory and antioxidant genes such as HMOX1 and SOD1; regulates signaling pathways related to neurodegeneration (TNF, TLR4, PI3K/Akt, etc.); and alleviates neuroinflammation by modulating multiple pathways. Additionally, berberine could enhance antioxidant and anti-inflammatory levels and mitigate inflammatory damage. Hence, berberine may exert therapeutic effects on <italic toggle="yes">S. suis</italic> meningitis through coordinated actions involving multiple targets and pathways. The mechanisms of action of these targets and signaling pathways require validation to serve as a basis for the clinical application of berberine.</p></sec><sec sec-type="conclusions" id="sec5-toxics-13-00138"><title>5. Conclusions</title><p>In summary, we analyzed the targets of berberine in the treatment of <italic toggle="yes">S. suis</italic> meningitis by using network pharmacology. Our findings indicate that berberine exerts its effect on <italic toggle="yes">S. suis</italic> meningitis through multiple targets and pathways, of which anti-inflammatory and antioxidant stress are key roles. Our findings provide a reference for the development of new drugs to treat humans and pigs with <italic toggle="yes">S. suis</italic> meningitis and new types of animal feed and environmentally friendly and antibiotic-free animal-derived food products. These endeavors should contribute to modernizing the farming industry.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-toxics-13-00138"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/article/10.3390/toxics13020138/s1">https://www.mdpi.com/article/10.3390/toxics13020138/s1</uri>, Table S1: The data details of <xref rid="toxics-13-00138-f002" ref-type="fig">Figure 2</xref>A&#x02013;C, Table S2: The data details of <xref rid="toxics-13-00138-f002" ref-type="fig">Figure 2</xref>D.</p><supplementary-material id="toxics-13-00138-s001" position="float" content-type="local-data"><media xlink:href="toxics-13-00138-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, J.X. and S.F.; methodology, P.G.; software, Y.X.; validation, D.Z., X.W. and Y.L.; formal analysis, Q.L.; investigation, C.Y.; resources, Y.Q.; data curation, Y.X.; writing&#x02014;original draft preparation, P.G., Y.X., D.Z., Y.L. and C.Y.; writing&#x02014;review and editing, Y.Q., X.W., Q.L., Z.W., J.X. and S.F.; visualization, Z.W.; supervision, X.W.; project administration, P.G.; funding acquisition, Y.Q. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>All data in this article are presented in the article.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest in this work.</p></notes><glossary><title>Abbreviation and Symbols</title><array><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">3D</td><td align="left" valign="middle" rowspan="1" colspan="1">three-dimensional</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CASP3</td><td align="left" valign="middle" rowspan="1" colspan="1">caspase-3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ERK</td><td align="left" valign="middle" rowspan="1" colspan="1">extracellular signal-regulated kinase 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FN1</td><td align="left" valign="middle" rowspan="1" colspan="1">fibronectin 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GO</td><td align="left" valign="middle" rowspan="1" colspan="1">Gene Ontology</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HMOX1</td><td align="left" valign="middle" rowspan="1" colspan="1">heme oxygenase 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ICAM-1</td><td align="left" valign="middle" rowspan="1" colspan="1">intercellular adhesion molecule 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL-17</td><td align="left" valign="middle" rowspan="1" colspan="1">interleukin 17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">JNK</td><td align="left" valign="middle" rowspan="1" colspan="1">c-Jun N-terminal kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KEGG</td><td align="left" valign="middle" rowspan="1" colspan="1">Kyoto Encyclopedia of Genes and Genomes</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KIM-1</td><td align="left" valign="middle" rowspan="1" colspan="1">kidney injury molecule-1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAPK</td><td align="left" valign="middle" rowspan="1" colspan="1">mitogen-associated protein kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MDA</td><td align="left" valign="middle" rowspan="1" colspan="1">malondialdehyde</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MIC</td><td align="left" valign="middle" rowspan="1" colspan="1">minimum inhibitory concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NF-&#x003ba;B</td><td align="left" valign="middle" rowspan="1" colspan="1">nuclear factor kappa-light-chain-enhancer of activated B cells</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NO</td><td align="left" valign="middle" rowspan="1" colspan="1">nitric oxide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PCR</td><td align="left" valign="middle" rowspan="1" colspan="1">polymerase chain reaction</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PI3K</td><td align="left" valign="middle" rowspan="1" colspan="1">phosphoinositide 3-kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PPI</td><td align="left" valign="middle" rowspan="1" colspan="1">protein&#x02013;protein interaction</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. scrofa</italic>
</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Sus scrofa</italic>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. suis</italic>
</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus suis</italic>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TGF-&#x003b2;</td><td align="left" valign="middle" rowspan="1" colspan="1">transforming growth factor beta</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TLR4</td><td align="left" valign="middle" rowspan="1" colspan="1">Toll-like receptor 4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TNF</td><td align="left" valign="middle" rowspan="1" colspan="1">tumor necrosis factor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TP53</td><td align="left" valign="middle" rowspan="1" colspan="1">tumor protein P53</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-toxics-13-00138"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liedel</surname><given-names>C.</given-names></name>
<name><surname>Rieckmann</surname><given-names>K.</given-names></name>
<name><surname>Baums</surname><given-names>C.G.</given-names></name>
</person-group><article-title>A critical review on experimental <italic toggle="yes">Streptococcus suis</italic> infection in pigs with a focus on clinical monitoring and refinement strategies</article-title><source>BMC Vet. Res.</source><year>2023</year><volume>19</volume><elocation-id>188</elocation-id><pub-id pub-id-type="doi">10.1186/s12917-023-03735-9</pub-id><pub-id pub-id-type="pmid">37798634</pub-id>
</element-citation></ref><ref id="B2-toxics-13-00138"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dutkiewicz</surname><given-names>J.</given-names></name>
<name><surname>Zaj&#x00105;c</surname><given-names>V.</given-names></name>
<name><surname>Sroka</surname><given-names>J.</given-names></name>
<name><surname>Wasi&#x00144;ski</surname><given-names>B.</given-names></name>
<name><surname>Cisak</surname><given-names>E.</given-names></name>
<name><surname>Sawczyn</surname><given-names>A.</given-names></name>
<name><surname>Kloc</surname><given-names>A.</given-names></name>
<name><surname>W&#x000f3;jcik-Fatla</surname><given-names>A.</given-names></name>
</person-group><article-title><italic toggle="yes">Streptococcus suis</italic>: A re-emerging pathogen asso-ciated with occupational exposure to pigs or pork products. Part ii&#x02014;Pathogenesis</article-title><source>Ann. Agric. Environ. Med.</source><year>2018</year><volume>25</volume><fpage>186</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.26444/aaem/85651</pub-id><pub-id pub-id-type="pmid">29575852</pub-id>
</element-citation></ref><ref id="B3-toxics-13-00138"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lun</surname><given-names>Z.R.</given-names></name>
<name><surname>Wang</surname><given-names>Q.P.</given-names></name>
<name><surname>Chen</surname><given-names>X.G.</given-names></name>
<name><surname>Li</surname><given-names>A.X.</given-names></name>
<name><surname>Zhu</surname><given-names>X.Q.</given-names></name>
</person-group><article-title><italic toggle="yes">Streptococcus suis</italic>: An emerging zoonotic pathogen</article-title><source>Lancet Infect. Dis.</source><year>2007</year><volume>7</volume><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(07)70001-4</pub-id><pub-id pub-id-type="pmid">17317601</pub-id>
</element-citation></ref><ref id="B4-toxics-13-00138"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Werinder</surname><given-names>A.</given-names></name>
<name><surname>Asp&#x000e1;n</surname><given-names>A.</given-names></name>
<name><surname>Backhans</surname><given-names>A.</given-names></name>
<name><surname>Sj&#x000f6;lund</surname><given-names>M.</given-names></name>
<name><surname>Guss</surname><given-names>B.</given-names></name>
<name><surname>Jacobson</surname><given-names>M.</given-names></name>
</person-group><article-title><italic toggle="yes">Streptococcus suis</italic> in swedish grower pigs: Occurrence, serotypes, and antimicrobial susceptibility</article-title><source>Acta Vet. Scand.</source><year>2020</year><volume>62</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/s13028-020-00533-3</pub-id><pub-id pub-id-type="pmid">32580735</pub-id>
</element-citation></ref><ref id="B5-toxics-13-00138"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>H.</given-names></name>
<name><surname>Jing</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>Z.</given-names></name>
<name><surname>Zheng</surname><given-names>H.</given-names></name>
<name><surname>Zhu</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Zu</surname><given-names>R.</given-names></name>
<name><surname>Luo</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Human <italic toggle="yes">Streptococcus suis</italic> outbreak, Sichuan, China</article-title><source>Emerg. Infect. Dis.</source><year>2006</year><volume>12</volume><fpage>914</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.3201/eid1206.051194</pub-id><pub-id pub-id-type="pmid">16707046</pub-id>
</element-citation></ref><ref id="B6-toxics-13-00138"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jover-Garc&#x000ed;a</surname><given-names>J.</given-names></name>
<name><surname>L&#x000f3;pez-Mill&#x000e1;n</surname><given-names>C.</given-names></name>
<name><surname>Gil-Tom&#x000e1;s</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Emerging infectious diseases: <italic toggle="yes">Streptococcus suis</italic> meningitis</article-title><source>Rev. Esp. Quimioter.</source><year>2020</year><volume>33</volume><fpage>385</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.37201/req/055.2020</pub-id><pub-id pub-id-type="pmid">32766669</pub-id>
</element-citation></ref><ref id="B7-toxics-13-00138"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ouattara</surname><given-names>M.</given-names></name>
<name><surname>Tamboura</surname><given-names>M.</given-names></name>
<name><surname>Kambire</surname><given-names>D.</given-names></name>
<name><surname>Sanou</surname><given-names>M.</given-names></name>
<name><surname>Ouattara</surname><given-names>K.</given-names></name>
<name><surname>Congo</surname><given-names>M.</given-names></name>
<name><surname>Kabor&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>Sanou</surname><given-names>S.</given-names></name>
<name><surname>Kabr&#x000e9;</surname><given-names>E.</given-names></name>
<name><surname>Sharpley</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Identification of <italic toggle="yes">Streptococcus suis</italic> meningitis by direct triplex real-time PCR, Burkina Faso</article-title><source>Emerg. Infect. Dis.</source><year>2020</year><volume>26</volume><fpage>2223</fpage><lpage>2226</lpage><pub-id pub-id-type="doi">10.3201/eid2609.200203</pub-id><pub-id pub-id-type="pmid">32818394</pub-id>
</element-citation></ref><ref id="B8-toxics-13-00138"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Susilawathi</surname><given-names>N.M.</given-names></name>
<name><surname>Tarini</surname><given-names>N.M.A.</given-names></name>
<name><surname>Fatmawati</surname><given-names>N.N.D.</given-names></name>
<name><surname>Mayura</surname><given-names>P.I.</given-names></name>
<name><surname>Suryapraba</surname><given-names>A.A.A.</given-names></name>
<name><surname>Subrata</surname><given-names>M.</given-names></name>
<name><surname>Mahardika</surname><given-names>G.N.</given-names></name>
</person-group><article-title><italic toggle="yes">Streptococcus suis</italic>-associated meningitis, Bali, Indonesia, 2014&#x02013;2017</article-title><source>Emerg. Infect. Dis.</source><year>2019</year><volume>25</volume><fpage>2235</fpage><lpage>2242</lpage><pub-id pub-id-type="doi">10.3201/eid2512.181709</pub-id><pub-id pub-id-type="pmid">31742523</pub-id>
</element-citation></ref><ref id="B9-toxics-13-00138"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rayanakorn</surname><given-names>A.</given-names></name>
<name><surname>Ademi</surname><given-names>Z.</given-names></name>
<name><surname>Liew</surname><given-names>D.</given-names></name>
<name><surname>Lee</surname><given-names>L.H.</given-names></name>
</person-group><article-title>Burden of disease and productivity impact of <italic toggle="yes">Streptococcus suis</italic> infection in thailand</article-title><source>PLoS Negl. Trop. Dis.</source><year>2021</year><volume>15</volume><elocation-id>e0008985</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0008985</pub-id><pub-id pub-id-type="pmid">33481785</pub-id>
</element-citation></ref><ref id="B10-toxics-13-00138"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brizuela</surname><given-names>J.</given-names></name>
<name><surname>Kajeekul</surname><given-names>R.</given-names></name>
<name><surname>Roodsant</surname><given-names>T.J.</given-names></name>
<name><surname>Riwload</surname><given-names>A.</given-names></name>
<name><surname>Boueroy</surname><given-names>P.</given-names></name>
<name><surname>Pattanapongpaibool</surname><given-names>A.</given-names></name>
<name><surname>Thaipadungpanit</surname><given-names>J.</given-names></name>
<name><surname>Jenjaroenpun</surname><given-names>P.</given-names></name>
<name><surname>Wongsurawat</surname><given-names>T.</given-names></name>
<name><surname>Batty</surname><given-names>E.M.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">Streptococcus suis</italic> outbreak caused by an emerging zoonotic strain with acquired multi-drug resistance in Thailand</article-title><source>Microb. Genom.</source><year>2023</year><volume>9</volume><fpage>mgen000952</fpage><pub-id pub-id-type="doi">10.1099/mgen.0.000952</pub-id><pub-id pub-id-type="pmid">36790403</pub-id>
</element-citation></ref><ref id="B11-toxics-13-00138"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Song</surname><given-names>D.</given-names></name>
<name><surname>Hao</surname><given-names>J.</given-names></name>
<name><surname>Fan</surname><given-names>D.</given-names></name>
</person-group><article-title>Biological properties and clinical applications of berberine</article-title><source>Front. Med.</source><year>2020</year><volume>14</volume><fpage>564</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1007/s11684-019-0724-6</pub-id><pub-id pub-id-type="pmid">32335802</pub-id>
</element-citation></ref><ref id="B12-toxics-13-00138"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>Q.</given-names></name>
<name><surname>Fu</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
</person-group><article-title>Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders</article-title><source>Pharmacol. Rep.</source><year>2022</year><volume>74</volume><fpage>297</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1007/s43440-021-00348-7</pub-id><pub-id pub-id-type="pmid">35083737</pub-id>
</element-citation></ref><ref id="B13-toxics-13-00138"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abd El-Wahab</surname><given-names>A.E.</given-names></name>
<name><surname>Ghareeb</surname><given-names>D.A.</given-names></name>
<name><surname>Sarhan</surname><given-names>E.E.</given-names></name>
<name><surname>Abu-Serie</surname><given-names>M.M.</given-names></name>
<name><surname>El Demellawy</surname><given-names>M.A.</given-names></name>
</person-group><article-title>In vitro biological assessment of berberis vulgaris and its active constituent, berberine: Antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects</article-title><source>BMC Complement. Altern. Med.</source><year>2013</year><volume>13</volume><elocation-id>218</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-13-218</pub-id><pub-id pub-id-type="pmid">24007270</pub-id>
</element-citation></ref><ref id="B14-toxics-13-00138"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Och</surname><given-names>A.</given-names></name>
<name><surname>Podg&#x000f3;rski</surname><given-names>R.</given-names></name>
<name><surname>Nowak</surname><given-names>R.</given-names></name>
</person-group><article-title>Biological activity of berberine-a summary update</article-title><source>Toxins</source><year>2020</year><volume>12</volume><elocation-id>713</elocation-id><pub-id pub-id-type="doi">10.3390/toxins12110713</pub-id><pub-id pub-id-type="pmid">33198257</pub-id>
</element-citation></ref><ref id="B15-toxics-13-00138"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y.H.</given-names></name>
<name><surname>Zhou</surname><given-names>Y.H.</given-names></name>
<name><surname>Ren</surname><given-names>Y.Z.</given-names></name>
<name><surname>Xu</surname><given-names>C.G.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>B.</given-names></name>
<name><surname>Chen</surname><given-names>J.Q.</given-names></name>
<name><surname>Ding</surname><given-names>W.Y.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.L.</given-names></name>
<name><surname>Yang</surname><given-names>Y.B.</given-names></name>
<etal/>
</person-group><article-title>Intervention effects of water extract, berberine hydrochloride and coptisine from rhizoma coptidis against <italic toggle="yes">Streptococcus suis</italic> biofilm in vitro</article-title><source>Chin. J. Vet. Med.</source><year>2015</year><volume>51</volume><fpage>16</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.3969/j.issn.0529-6005.2015.04.005</pub-id></element-citation></ref><ref id="B16-toxics-13-00138"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Berberine protects against neurological impairments and blood-brain barrier injury in mouse model of intracerebral hemorrhage</article-title><source>Neuroimmunomodula</source><year>2022</year><volume>29</volume><fpage>317</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1159/000520747</pub-id></element-citation></ref><ref id="B17-toxics-13-00138"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ibrahim Fouad</surname><given-names>G.</given-names></name>
<name><surname>Ahmed</surname><given-names>K.A.</given-names></name>
</person-group><article-title>Neuroprotective potential of berberine against doxorubicin-induced toxicity in rat&#x02019;s brain</article-title><source>Neurochem. Res.</source><year>2021</year><volume>46</volume><fpage>3247</fpage><lpage>3263</lpage><pub-id pub-id-type="doi">10.1007/s11064-021-03428-5</pub-id><pub-id pub-id-type="pmid">34403065</pub-id>
</element-citation></ref><ref id="B18-toxics-13-00138"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aski</surname><given-names>M.L.</given-names></name>
<name><surname>Rezvani</surname><given-names>M.E.</given-names></name>
<name><surname>Khaksari</surname><given-names>M.</given-names></name>
<name><surname>Hafizi</surname><given-names>Z.</given-names></name>
<name><surname>Pirmoradi</surname><given-names>Z.</given-names></name>
<name><surname>Niknazar</surname><given-names>S.</given-names></name>
<name><surname>Mehrjerdi</surname><given-names>F.Z.</given-names></name>
</person-group><article-title>Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia</article-title><source>Iran J. Basic Med. Sci.</source><year>2018</year><volume>21</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.22038/ijbms.2017.23195.5865</pub-id><pub-id pub-id-type="pmid">29372037</pub-id>
</element-citation></ref><ref id="B19-toxics-13-00138"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>C.</given-names></name>
<name><surname>Yu</surname><given-names>T.</given-names></name>
<name><surname>Zhu</surname><given-names>R.</given-names></name>
<name><surname>Lu</surname><given-names>J.</given-names></name>
<name><surname>Ouyang</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Chen</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Cui</surname><given-names>J.</given-names></name>
<name><surname>Jiang</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Timosaponin aiii promotes non-small-cell lung cancer ferroptosis through targeting and facilitating Hsp90 mediated Gpx4 ubiquitination and degradation</article-title><source>Int. J. Biol. Sci.</source><year>2023</year><volume>19</volume><fpage>1471</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.7150/ijbs.77979</pub-id><pub-id pub-id-type="pmid">37056925</pub-id>
</element-citation></ref><ref id="B20-toxics-13-00138"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shang</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Zhou</surname><given-names>F.</given-names></name>
<name><surname>Xiao</surname><given-names>K.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Yang</surname><given-names>S.</given-names></name>
</person-group><article-title>Mechanism of sijunzi decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation</article-title><source>J. Ethnopharmacol.</source><year>2023</year><volume>302</volume><fpage>115876</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2022.115876</pub-id><pub-id pub-id-type="pmid">36343798</pub-id>
</element-citation></ref><ref id="B21-toxics-13-00138"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>H.</given-names></name>
<name><surname>Lou</surname><given-names>C.</given-names></name>
<name><surname>Sun</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Cai</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Liu</surname><given-names>G.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Admetsar 2.0: Web-service for prediction and optimization of chemical admet properties</article-title><source>Bioinformatics</source><year>2019</year><volume>35</volume><fpage>1067</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty707</pub-id><pub-id pub-id-type="pmid">30165565</pub-id>
</element-citation></ref><ref id="B22-toxics-13-00138"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stelzer</surname><given-names>G.</given-names></name>
<name><surname>Rosen</surname><given-names>N.</given-names></name>
<name><surname>Plaschkes</surname><given-names>I.</given-names></name>
<name><surname>Zimmerman</surname><given-names>S.</given-names></name>
<name><surname>Twik</surname><given-names>M.</given-names></name>
<name><surname>Fishilevich</surname><given-names>S.</given-names></name>
<name><surname>Stein</surname><given-names>T.I.</given-names></name>
<name><surname>Nudel</surname><given-names>R.</given-names></name>
<name><surname>Lieder</surname><given-names>I.</given-names></name>
<name><surname>Mazor</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>The genecards suite: From gene data mining to disease genome sequence analyses</article-title><source>Curr. Protoc. Bioinform.</source><year>2016</year><volume>54</volume><fpage>1.30.1</fpage><lpage>1.30.33</lpage><pub-id pub-id-type="doi">10.1002/cpbi.5</pub-id><pub-id pub-id-type="pmid">27322403</pub-id>
</element-citation></ref><ref id="B23-toxics-13-00138"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stevens</surname><given-names>T.</given-names></name>
<name><surname>Sangkuhl</surname><given-names>K.</given-names></name>
<name><surname>Brown</surname><given-names>J.T.</given-names></name>
<name><surname>Altman</surname><given-names>R.B.</given-names></name>
<name><surname>Klein</surname><given-names>T.E.</given-names></name>
</person-group><article-title>Pharmgkb summary: Methylphenidate pathway, pharmaco-kinetics/pharmacodynamics</article-title><source>Pharmacogenet. Genom.</source><year>2019</year><volume>29</volume><fpage>136</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1097/FPC.0000000000000376</pub-id><pub-id pub-id-type="pmid">30950912</pub-id>
</element-citation></ref><ref id="B24-toxics-13-00138"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Zhao</surname><given-names>D.</given-names></name>
<name><surname>Yu</surname><given-names>X.</given-names></name>
<name><surname>Shen</surname><given-names>X.</given-names></name>
<name><surname>Zhou</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Qiu</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Zhu</surname><given-names>F.</given-names></name>
</person-group><article-title>TTD: Therapeutic target database describing target druggability information</article-title><source>Nucleic Acids Res.</source><year>2023</year><volume>52</volume><fpage>1465</fpage><lpage>1477</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad751</pub-id></element-citation></ref><ref id="B25-toxics-13-00138"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Jing</surname><given-names>T.</given-names></name>
</person-group><article-title>A novel signature of combing cuproptosis- with ferroptosis-related genes for prediction of prognosis, immunologic therapy responses and drug sensitivity in hepatocellular carcinoma</article-title><source>Front. Oncol.</source><year>2022</year><volume>12</volume><elocation-id>1000993</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2022.1000993</pub-id><pub-id pub-id-type="pmid">36249031</pub-id>
</element-citation></ref><ref id="B26-toxics-13-00138"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hao</surname><given-names>N.</given-names></name>
<name><surname>Sun</surname><given-names>P.</given-names></name>
<name><surname>Zhao</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
</person-group><article-title>Application of a developed triple-classification machine learning model for carcinogenic prediction of hazardous organic chemicals to the US, EU, and who based on Chinese database</article-title><source>Ecotoxicol. Environ. Saf.</source><year>2023</year><volume>255</volume><fpage>114806</fpage><pub-id pub-id-type="doi">10.1016/j.ecoenv.2023.114806</pub-id><pub-id pub-id-type="pmid">36948010</pub-id>
</element-citation></ref><ref id="B27-toxics-13-00138"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Del Conte</surname><given-names>A.</given-names></name>
<name><surname>Monzon</surname><given-names>A.M.</given-names></name>
<name><surname>Clementel</surname><given-names>D.</given-names></name>
<name><surname>Camagni</surname><given-names>G.F.</given-names></name>
<name><surname>Minervini</surname><given-names>G.</given-names></name>
<name><surname>E Tosatto</surname><given-names>S.C.</given-names></name>
<name><surname>Piovesan</surname><given-names>D.</given-names></name>
</person-group><article-title>Ring-pymol: Residue interaction networks of structural ensembles and molecular dynamics</article-title><source>Bioinformatics</source><year>2023</year><volume>39</volume><elocation-id>btad260</elocation-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btad260</pub-id><pub-id pub-id-type="pmid">37079739</pub-id>
</element-citation></ref><ref id="B28-toxics-13-00138"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>P.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Tang</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
</person-group><article-title>Prevalence of Streptococcus suis in pigs in China during 2000&#x02013;2021: A systematic review and meta-analysis</article-title><source>One Health</source><year>2023</year><volume>16</volume><fpage>100513</fpage><pub-id pub-id-type="doi">10.1016/j.onehlt.2023.100513</pub-id><pub-id pub-id-type="pmid">37363255</pub-id>
</element-citation></ref><ref id="B29-toxics-13-00138"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guo</surname><given-names>Z.</given-names></name>
<name><surname>Zhao</surname><given-names>F.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Geng</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Ma</surname><given-names>Q.</given-names></name>
<name><surname>Xu</surname><given-names>X.</given-names></name>
</person-group><article-title>Sevoflurane exerts an anti-depressive action by blocking the HMGB1/TLR4 pathway in unpredictable chronic mild stress rats</article-title><source>J. Mol. Neurosci.</source><year>2019</year><volume>69</volume><fpage>546</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1007/s12031-019-01380-2</pub-id><pub-id pub-id-type="pmid">31368063</pub-id>
</element-citation></ref><ref id="B30-toxics-13-00138"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hutchinson</surname><given-names>M.R.</given-names></name>
<name><surname>Shavit</surname><given-names>Y.</given-names></name>
<name><surname>Grace</surname><given-names>P.M.</given-names></name>
<name><surname>Rice</surname><given-names>K.C.</given-names></name>
<name><surname>Maier</surname><given-names>S.F.</given-names></name>
<name><surname>Watkins</surname><given-names>L.R.</given-names></name>
</person-group><article-title>Exploring the neuroimmunopharmacology of opioids: An integrative review of mechanisms of central immune signaling and their implications for opioid analgesia</article-title><source>Pharmacol. Rev.</source><year>2011</year><volume>63</volume><fpage>772</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1124/pr.110.004135</pub-id><pub-id pub-id-type="pmid">21752874</pub-id>
</element-citation></ref><ref id="B31-toxics-13-00138"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>J.</given-names></name>
<name><surname>Hutchinson</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids</article-title><source>Expert Rev. Neurother.</source><year>2012</year><volume>12</volume><fpage>1311</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1586/ern.12.125</pub-id><pub-id pub-id-type="pmid">23234393</pub-id>
</element-citation></ref><ref id="B32-toxics-13-00138"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>P.</given-names></name>
<name><surname>Yang</surname><given-names>M.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Wei</surname><given-names>X.</given-names></name>
<name><surname>Zeng</surname><given-names>S.</given-names></name>
</person-group><article-title>Toll-like receptor 4 (TLR4)/opioid receptor pathway crosstalk and impact on opioid analgesia, immune function, and gastrointestinal motility</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>1455</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01455</pub-id><pub-id pub-id-type="pmid">32733481</pub-id>
</element-citation></ref><ref id="B33-toxics-13-00138"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Madera-Salcedo</surname><given-names>I.K.</given-names></name>
<name><surname>Cruz</surname><given-names>S.L.</given-names></name>
<name><surname>Gonzalez-Espinosa</surname><given-names>C.</given-names></name>
</person-group><article-title>Morphine prevents lipopolysaccharide-induced TNF secretion in mast cells blocking I&#x003ba;B kinase activation and SNAP-23 phosphorylation: Correlation with the formation of a &#x003b2;-arrestin/TRAF6 complex</article-title><source>J. Immunol.</source><year>2013</year><volume>191</volume><fpage>3400</fpage><lpage>3409</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202658</pub-id><pub-id pub-id-type="pmid">23960234</pub-id>
</element-citation></ref><ref id="B34-toxics-13-00138"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Loo</surname><given-names>G.</given-names></name>
<name><surname>Bertrand</surname><given-names>M.J.M.</given-names></name>
</person-group><article-title>Death by TNF: A road to inflammation</article-title><source>Nat. Rev. Immunol.</source><year>2023</year><volume>23</volume><fpage>289</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1038/s41577-022-00792-3</pub-id><pub-id pub-id-type="pmid">36380021</pub-id>
</element-citation></ref><ref id="B35-toxics-13-00138"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dou</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
</person-group><article-title>Upregulation of CCT3 promotes cervical cancer progression through FN1</article-title><source>Mol. Med. Rep.</source><year>2021</year><volume>24</volume><fpage>856</fpage><pub-id pub-id-type="doi">10.3892/mmr.2021.12496</pub-id><pub-id pub-id-type="pmid">34651664</pub-id>
</element-citation></ref><ref id="B36-toxics-13-00138"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>Q.</given-names></name>
<name><surname>Xie</surname><given-names>J.</given-names></name>
<name><surname>Xie</surname><given-names>J.</given-names></name>
<name><surname>Zhao</surname><given-names>R.</given-names></name>
<name><surname>Song</surname><given-names>C.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Rong</surname><given-names>J.</given-names></name>
<name><surname>Yan</surname><given-names>L.</given-names></name>
<name><surname>Song</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Weighted correlation network analysis identifies FN1, COL1A1 and serpine1 associated with the progression and prognosis of gastric cancer</article-title><source>Cancer Biomark.</source><year>2021</year><volume>31</volume><fpage>59</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.3233/CBM-200594</pub-id><pub-id pub-id-type="pmid">33780362</pub-id>
</element-citation></ref><ref id="B37-toxics-13-00138"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>D.-L.</given-names></name>
<name><surname>Wang</surname><given-names>J.-M.</given-names></name>
<name><surname>Wu</surname><given-names>T.</given-names></name>
<name><surname>Du</surname><given-names>X.</given-names></name>
<name><surname>Yan</surname><given-names>J.</given-names></name>
<name><surname>Du</surname><given-names>Z.-X.</given-names></name>
<name><surname>Wang</surname><given-names>H.-Q.</given-names></name>
</person-group><article-title>BAG5 promotes invasion of papillary thyroid cancer cells via upregulation of fibronectin 1 at the translational level</article-title><source>Biochim. Biophys. Acta Mol. Cell Res.</source><year>2020</year><volume>1867</volume><elocation-id>118715</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbamcr.2020.118715</pub-id><pub-id pub-id-type="pmid">32275930</pub-id>
</element-citation></ref><ref id="B38-toxics-13-00138"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Geng</surname><given-names>Q.S.</given-names></name>
<name><surname>Huang</surname><given-names>T.</given-names></name>
<name><surname>Li</surname><given-names>L.F.</given-names></name>
<name><surname>Shen</surname><given-names>Z.B.</given-names></name>
<name><surname>Xue</surname><given-names>W.H.</given-names></name>
<name><surname>Zhao</surname><given-names>J.</given-names></name>
</person-group><article-title>Over-expression and prognostic significance of FN1, correlating with immune infiltrates in thyroid cancer</article-title><source>Front. Med.</source><year>2021</year><volume>8</volume><elocation-id>812278</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2021.812278</pub-id><pub-id pub-id-type="pmid">35141255</pub-id>
</element-citation></ref><ref id="B39-toxics-13-00138"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Yu</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>He</surname><given-names>Y.</given-names></name>
</person-group><article-title>FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers</article-title><source>Front. Oncol.</source><year>2022</year><volume>12</volume><elocation-id>918719</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2022.918719</pub-id><pub-id pub-id-type="pmid">36081567</pub-id>
</element-citation></ref><ref id="B40-toxics-13-00138"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gong</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Z.X.</given-names></name>
<name><surname>Liu</surname><given-names>Z.Y.</given-names></name>
</person-group><article-title>Mirna-1271 inhibits cell proliferation in neuroglioma by targeting fibronectin 1</article-title><source>Mol. Med. Rep.</source><year>2017</year><volume>16</volume><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.3892/mmr.2017.6610</pub-id><pub-id pub-id-type="pmid">28535003</pub-id>
</element-citation></ref><ref id="B41-toxics-13-00138"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Purves-Tyson</surname><given-names>T.D.</given-names></name>
<name><surname>Robinson</surname><given-names>K.</given-names></name>
<name><surname>Brown</surname><given-names>A.M.</given-names></name>
<name><surname>Boerrigter</surname><given-names>D.</given-names></name>
<name><surname>Cai</surname><given-names>H.Q.</given-names></name>
<name><surname>Weissleder</surname><given-names>C.</given-names></name>
<name><surname>Owens</surname><given-names>S.J.</given-names></name>
<name><surname>Rothmond</surname><given-names>D.A.</given-names></name>
<name><surname>Weickert</surname><given-names>C.S.</given-names></name>
</person-group><article-title>Increased macrophages and C1QA, C3, C4 transcripts in the midbrain of people with schizophrenia</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>2002</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.02002</pub-id><pub-id pub-id-type="pmid">33133060</pub-id>
</element-citation></ref><ref id="B42-toxics-13-00138"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>C.H.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Sims</surname><given-names>M.</given-names></name>
<name><surname>Cai</surname><given-names>C.</given-names></name>
<name><surname>Pfeffer</surname><given-names>L.M.</given-names></name>
</person-group><article-title>Microrna-1 suppresses glioblastoma in preclinical models by targeting fibronectin</article-title><source>Cancer Lett.</source><year>2019</year><volume>465</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2019.08.021</pub-id><pub-id pub-id-type="pmid">31491450</pub-id>
</element-citation></ref><ref id="B43-toxics-13-00138"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miao</surname><given-names>L.</given-names></name>
<name><surname>St Clair</surname><given-names>D.K.</given-names></name>
</person-group><article-title>Regulation of superoxide dismutase genes: Implications in disease</article-title><source>Free Radic. Biol. Med.</source><year>2009</year><volume>47</volume><fpage>344</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.05.018</pub-id><pub-id pub-id-type="pmid">19477268</pub-id>
</element-citation></ref><ref id="B44-toxics-13-00138"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Trist</surname><given-names>B.G.</given-names></name>
<name><surname>Hilton</surname><given-names>J.B.</given-names></name>
<name><surname>Hare</surname><given-names>D.J.</given-names></name>
<name><surname>Crouch</surname><given-names>P.J.</given-names></name>
<name><surname>Double</surname><given-names>K.L.</given-names></name>
</person-group><article-title>Superoxide dismutase 1 in health and disease: How&#x02009;a&#x02009;frontline antioxidant becomes neurotoxic</article-title><source>Angew. Chem. Int. Ed. Engl.</source><year>2021</year><volume>60</volume><fpage>9215</fpage><lpage>9246</lpage><pub-id pub-id-type="doi">10.1002/anie.202000451</pub-id><pub-id pub-id-type="pmid">32144830</pub-id>
</element-citation></ref><ref id="B45-toxics-13-00138"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Loboda</surname><given-names>A.</given-names></name>
<name><surname>Damulewicz</surname><given-names>M.</given-names></name>
<name><surname>Pyza</surname><given-names>E.</given-names></name>
<name><surname>Jozkowicz</surname><given-names>A.</given-names></name>
<name><surname>Dulak</surname><given-names>J.</given-names></name>
</person-group><article-title>Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism</article-title><source>Cell Mol. Life Sci.</source><year>2016</year><volume>73</volume><fpage>3221</fpage><lpage>3247</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2223-0</pub-id><pub-id pub-id-type="pmid">27100828</pub-id>
</element-citation></ref><ref id="B46-toxics-13-00138"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bao</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Zha</surname><given-names>D.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Gao</surname><given-names>P.</given-names></name>
<name><surname>Yao</surname><given-names>T.</given-names></name>
<name><surname>Wu</surname><given-names>X.</given-names></name>
</person-group><article-title>Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-&#x00138;B pathways</article-title><source>Int. Immunopharmacol.</source><year>2018</year><volume>54</volume><fpage>245</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2017.11.021</pub-id><pub-id pub-id-type="pmid">29161661</pub-id>
</element-citation></ref><ref id="B47-toxics-13-00138"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ryter</surname><given-names>S.W.</given-names></name>
<name><surname>Choi</surname><given-names>A.M.</given-names></name>
</person-group><article-title>Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation</article-title><source>Transl. Res.</source><year>2016</year><volume>167</volume><fpage>7</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2015.06.011</pub-id><pub-id pub-id-type="pmid">26166253</pub-id>
</element-citation></ref><ref id="B48-toxics-13-00138"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ping</surname><given-names>L.I.</given-names></name>
<name><surname>Jingjing</surname><given-names>Y.</given-names></name>
<name><surname>Da</surname><given-names>Z.</given-names></name>
<name><surname>Wenyan</surname><given-names>N.</given-names></name>
<name><surname>Qing</surname><given-names>H.E.</given-names></name>
<name><surname>Endocrinology</surname><given-names>D.O.</given-names></name>
</person-group><article-title>Effects of berberine on inflammatory FAC-TORS, adipokines and fatty acid metabolism in 3T3-L1 adipocytes</article-title><source>Tianjin Med. J.</source><year>2014</year><volume>6</volume><fpage>513</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.3969/j.issn.0253-9896.2014.06.001</pub-id></element-citation></ref><ref id="B49-toxics-13-00138"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
<name><surname>Du</surname><given-names>N.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Cheng</surname><given-names>F.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Berberine hydrochloride prevents postsurgery intestinal adhesion and inflammation in rats</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2014</year><volume>349</volume><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1124/jpet.114.212795</pub-id><pub-id pub-id-type="pmid">24676878</pub-id>
</element-citation></ref><ref id="B50-toxics-13-00138"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Akhzari</surname><given-names>M.</given-names></name>
<name><surname>Barazesh</surname><given-names>M.</given-names></name>
<name><surname>Jalili</surname><given-names>S.</given-names></name>
<name><surname>Farzinezhadi Zadeh</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Berberine recovered oxidative stress induced by sodium nitrite in rat erythrocytes</article-title><source>Drug Metab. Bioanal. Lett.</source><year>2022</year><volume>15</volume><fpage>192</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.2174/2949681015666220902114519</pub-id><pub-id pub-id-type="pmid">36056864</pub-id>
</element-citation></ref><ref id="B51-toxics-13-00138"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mombeini</surname><given-names>M.A.</given-names></name>
<name><surname>Kalantar</surname><given-names>H.</given-names></name>
<name><surname>Sadeghi</surname><given-names>E.</given-names></name>
<name><surname>Goudarzi</surname><given-names>M.</given-names></name>
<name><surname>Khalili</surname><given-names>H.</given-names></name>
<name><surname>Kalantar</surname><given-names>M.</given-names></name>
</person-group><article-title>Protective effects of berberine as a natural antioxidant and anti-inflammatory agent against nephrotoxicity induced by cyclophosphamide in mice</article-title><source>Naunyn Schmiedebergs Arch. Pharmacol.</source><year>2022</year><volume>395</volume><fpage>187</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1007/s00210-021-02182-3</pub-id><pub-id pub-id-type="pmid">34994821</pub-id>
</element-citation></ref><ref id="B52-toxics-13-00138"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>C.Y.</given-names></name>
<name><surname>Kao</surname><given-names>C.L.</given-names></name>
<name><surname>Liu</surname><given-names>C.M.</given-names></name>
</person-group><article-title>The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>2729</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19092729</pub-id><pub-id pub-id-type="pmid">30213077</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="toxics-13-00138-f001"><label>Figure 1</label><caption><p>Illustration of the study strategy. (TCMSP means Traditional Chinese Medicine Systems Pharmacology Database).</p></caption><graphic xlink:href="toxics-13-00138-g001" position="float"/></fig><fig position="float" id="toxics-13-00138-f002"><label>Figure 2</label><caption><p>Berberine and streptococcal meningitis targets. (<bold>A</bold>) Human <italic toggle="yes">S. suis</italic> meningitis targets. (<bold>B</bold>) Porcine <italic toggle="yes">S. suis</italic> meningitis targets. (<bold>C</bold>) Berberine targets. (<bold>D</bold>) Venn diagram of the three groups of targets. (Note: green represents berberine targets; blue represents porcine <italic toggle="yes">S. suis</italic> meningitis targets; and Cyan represents Human S. suis meningitis targets; the data details of <xref rid="toxics-13-00138-f002" ref-type="fig">Figure 2</xref> in <xref rid="app1-toxics-13-00138" ref-type="app">Supplementary Materials Tables S1 and S2</xref>).</p></caption><graphic xlink:href="toxics-13-00138-g002" position="float"/></fig><fig position="float" id="toxics-13-00138-f003"><label>Figure 3</label><caption><p>Screening of the core targets of berberine in alleviating meningitis in pigs and humans based on the STRING database and Cytoscape. (<bold>A</bold>) Cytoscape analysis of the interconnection of berberine and <italic toggle="yes">S. suis</italic> meningitis targets (Note: green represents berberine targets; blue represents porcine <italic toggle="yes">S. suis</italic> meningitis targets; and Cyan represents Human <italic toggle="yes">S. suis</italic> meningitis targets.). (<bold>B</bold>) Cytoscape parameters (betweenness &#x0003e; 210.52351395, closeness &#x0003e; 0.203574975, and degree &#x0003e; 11) were set to evaluate the relationship between the key targets (Note: green represents berberine targets; blue represents porcine <italic toggle="yes">S. suis</italic> meningitis targets; and Cyan represents Human <italic toggle="yes">S. suis</italic> meningitis targets.). (<bold>C</bold>) Core targets for further screening based on the Cytoscape database.</p></caption><graphic xlink:href="toxics-13-00138-g003" position="float"/></fig><fig position="float" id="toxics-13-00138-f004"><label>Figure 4</label><caption><p>Molecular docking diagram. Molecular models of the binding of berberine with human and porcine TLR4 and FN1. The results are shown as 3D and 2D diagrams: (<bold>A</bold>,<bold>a</bold>) berberine&#x02013;TLR4 (docking score = 4.17) in humans. (<bold>B</bold>,<bold>b</bold>) Berberine&#x02013;TLR4 (docking score = 4.19) in pigs. (<bold>C</bold>,<bold>c</bold>) Berberine&#x02013;FN1 (docking score = 3.78) in humans. (<bold>D</bold>,<bold>d</bold>) Berberine&#x02013;FN1 (docking score = 4.35) in pigs.</p></caption><graphic xlink:href="toxics-13-00138-g004" position="float"/></fig><fig position="float" id="toxics-13-00138-f005"><label>Figure 5</label><caption><p>(<bold>A</bold>) GO and (<bold>B</bold>) KEGG enrichment analysis of potential targets of berberine to alleviate <italic toggle="yes">S. suis</italic> meningitis.</p></caption><graphic xlink:href="toxics-13-00138-g005" position="float"/></fig><table-wrap position="float" id="toxics-13-00138-t001"><object-id pub-id-type="pii">toxics-13-00138-t001_Table 1</object-id><label>Table 1</label><caption><p>Prediction of ADMET for berberine.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Model Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Berberine</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Model Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Berberine</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ames mutagenesis</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">Honey bee toxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Acute Oral Toxicity (c)</td><td align="center" valign="middle" rowspan="1" colspan="1">III</td><td align="center" valign="middle" rowspan="1" colspan="1">Hepatotoxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Androgen receptor binding</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">Human Ether-a-go-go-Related Gene inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Aromatase binding</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">Human Intestinal Absorption</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Avian toxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">Human oral bioavailability</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Blood&#x02013;Brain Barrier</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">MATE1 inhibitior</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BRCP inhibitior</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">Mitochondrial toxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Biodegradation</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">Micronuclear</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BSEP inhibitior</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">Nephrotoxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Caco-2</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">Acute Oral Toxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">1.588989</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Carcinogenicity (binary)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">OATP1B1 inhibitior</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Carcinogenicity (trinary)</td><td align="center" valign="middle" rowspan="1" colspan="1">Non-required</td><td align="center" valign="middle" rowspan="1" colspan="1">OATP1B3 inhibitior</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Crustacea aquatic toxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">OATP2B1 inhibitior</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CYP1A2 inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">OCT1 inhibitior</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CYP2C19 inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">OCT2 inhibitior</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CYP2C9 inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">P-glycoprotein inhibitior</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CYP2C9 substrate</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">P-glycoprotein substrate</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CYP2D6 inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">PPAR gamma</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CYP2D6 substrate</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">Plasma protein binding</td><td align="center" valign="middle" rowspan="1" colspan="1">0.850641</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CYP3A4 inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">Reproductive toxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CYP3A4 substrate</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">Respiratory toxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CYP inhibitory promiscuity</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">skin sensitisation</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Eye corrosion</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">Subcellular localzation</td><td align="center" valign="middle" rowspan="1" colspan="1">Mitochondria</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Eye irritation</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">Tetrahymena pyriformis</td><td align="center" valign="middle" rowspan="1" colspan="1">1.632231</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Estrogen receptor binding</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">Thyroid receptor binding</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fish aquatic toxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">UGT catelyzed</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glucocorticoid receptor binding</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">+</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Water solubility</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;2.97369</td></tr></tbody></table></table-wrap></floats-group></article>